Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Biogen Idec

    Biogen Idec, Inc. () is an American biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer.

    Read More at Wikipedia ›

    Related Topics

    1. Genzyme
    2. Biotechnology
    3. Chesapeake Energy Corp.
    4. Pharmaceuticals
    5. Sherwin-Williams
    6. O'Reilly Automotive
    Get updates on Biogen Idec
    Health Care Sector Wrap

    The S&P 500 lost 0.

    9% while the Health Care sector (XLV) showed little movement during trading today.While being down today, the ETF, as a proxy for sector performance, tracked closer to the overall market today than over the past month. Entering today's trading, XLV was down 2.8% over the last thirty trading days while the S&P 500 was down 5.8%.Electromed (AMEX:ELMD) was a significant gainer in the sector, rising 9.6%. The stock closed at $2.63 with 17,126 shares moving. The stock traded in a range of $2.30 to $2.85.SKYSTAR BIO-PHARMACEUTICAL COMPANY (NASDAQ:SKBI) rose 6.8% to close at $2.67, cross its 50-day moving average of $2.56 and 200-day moving average of $2.66.Concord Medical Services Hldg (NYSE:CCM) rose 4.9% to close at $3.41, approaching its 50-day moving average of $3.66. It has also moved closer to its 200-day moving average of $3.65. Biogen Idec (NASDAQ:ATRI) fell 1% to close at $131.58, moving closer to its 50-day moving average of $130.26. Also, the stock moved closer ...

    Read More ›

    1. The Coca-Cola Company, Seagate Technology, Other Stocks Hit 52-Week Highs Wednesday

      Here are nine stocks that hit 52-week highs:The share price of The Coca-Cola Company (NYSE:KO) went up today, reaching and then surpassing its previous 52-week high ...

    2. Biogen Says Data Highlight Safety Profile For BG-12 MS Drug

      The latest data on Biogen Idec Inc.'s (BIIB) experimental multiple-sclerosis pill BG-12 show "favorable safety and tolerability" that support the drug's use as a fro...

    3. EARNINGS PREVIEW: US Biotechs' 1Q To Focus On Deals, Pipelines

      TAKING THE PULSE: Investors will likely focus on efforts by large U.S. biopharmaceutical companies to expand their drug pipelines likely as these firms report first-...

    4. Novartis MS Pill Gilenya Patient Gets Rare Brain Disease

      Novartis AG (NVS) Friday said a patient treated with its multiple-sclerosis pill Gilenya has been diagnosed with a rare and often fatal brain disease.The Swiss drug ...

    5. Novartis: MS Pill Gilenya Patient Develops Rare Brain Disease

      Novartis AG (NVS) Friday said a patient treated with its multiple-sclerosis pill Gilenya has been diagnosed with a rare and often fatal brain disease.The Swiss drug ...

    6. Icahn Says Sues Amylin, Urges Sale

      Carl Icahn sued Amylin Pharmaceuticals Inc to block enforcement of a bylaw that prevents the billionaire investor from launching a proxy fight that could lead to a s...

    7. Leading the Hedge-Fund World, Dalio Rakes in $3.9B in 2011

      As Americans dream about what they would do if they won the $540 million Mega Millions jackpot, hedge-fund heavyweight Ray Dalio knows he already banked more than se...

    8. Warburg Pincus Hires Francesco Granata To Identify Healthcare Deals

      Warburg Pincus said Monday it has appointed healthcare executive Francesco Granata to help the global buyout firm identify and evaluate deals in the biopharmaceutica...

    9. Biogen 4Q Net Up 25%; Investing In Pipeline

      Biogen Idec Inc. (BIIB) said Tuesday its fourth-quarter earnings rose 25%, fueled by rising sales of multiple sclerosis drugs, and added that the company is making i...

    10. Biogen 4Q Net Up 25% As Company Invests In Pipeline

      Biogen Idec Inc. (BIIB) said Tuesday its fourth-quarter earnings rose 25%, fueled by rising sales of multiple sclerosis drugs, and that the company is making investm...

    11. EARNINGS PREVIEW: US Biotechs' 4Q Focus On Pipelines, Deals

      TAKING THE PULSE: Large biopharmaceutical companies, as they have matured, have come to resemble many traditional drug makers and have been facing some of the same i...

    12. INTERVIEW-Biogen CEO hopes Icahn board members will stay on

       BOSTON (Reuters) - The chief executive of Biogen Idec Inc said he wants members of the biotechnology company's board who were originally nominated by activist inves...

    1. WSJ BLOG/Health: New Caution Urged Over Sole Oral MS Drug On the Market

      The FDA says the only oral multiple-sclerosis drug on the market -- Novartis's Gilenya -- shouldn't be used in patients with a recent history of stroke or some heart...

    2. FDA Concludes Safety Review Of Novartis MS Drug Gilenya

      The U.S. Food and Drug Administration Monday said Novartis AG's (NVS, NOVN.VX) multiple-sclerosis drug Gilenya shouldn't be used in patients with a recent history of...

    3. AT&T, Verizon Communications, Other Stocks Hit 52-Week Highs Friday

      These nine stocks hit 52-week highs:The share price of AT&T (NYSE:T) increased today, reaching and then surpassing its previous 52-week high of $33.33. In spite of i...

    4. CVS Caremark, CF Industries Holdings Among Stocks Setting 52-Week Highs Wednesday

      These are the nine most popular stocks that rose to 52-week highs:While trading on above-average volume, CVS Caremark (NYSE:CVS) climbed today, reaching and then sur...

    5. BP plc, Research In Motion Among Stocks Down on High Volume Tuesday

      Today, a few stocks are down on high volume:Trading at a volume of 9.3 million, or 1.6 its average daily volume, BP plc (NYSE:BP) was down on high volume today. The ...

    6. Biogen 1Q Profit Up, But Hurt By Purchasing Issue

      Biogen Idec Inc.'s (BIIB) first-quarter earnings rose 2.8%, missing Wall Street expectations after the company's flagship drug ran into a temporary wholesale purchas...

    7. U.S. Bancorp, The TJX Companies Among Stocks Hitting 52-Week Highs Friday

      These nine stocks reached 52-week highs:While trading on above-average volume, U.S. Bancorp (NYSE:USB) climbed today, reaching and then surpassing its previous 52-we...

    ‹ Prev12Next ›
    Freebase CC-BY
    Source: Biogen Idec on Freebase, licensed under CC-BY
    Other content from Wikipedia, licensed under the GFDL